FAQ

Pregnancy does not affect the interpretation of a Proteomis profile.

This is not the case for lipid-lowering drugs, cortisone and immunosuppressive therapies in general. Your doctor must take into account these drugs when interpreting the profile.

The only risks involved in a Proteomis analysis are the same as when taking a venous blood sample – as with any customary blood test.

The potential risks relating to the use of natural products cannot be indicated. These depend on how they are applied and the dosage used – hence the importance of your doctor's advice. Since the implementation of this method, no incidents have been reported, indicating that treatments are well tolerated.

This is a complementary medical technique that works alongside conventional medical practices. Firstly, it can be not only difficult but also dangerous for patients to stop taking long-term medical treatments. On the other hand, Proteomis profile aims to improve patient comfort by allowing them to reduce the amount of medications they take.

This is a simple blood test, no different from ones that pregnant women regularly take. Profiles can be drawn up during pregnancy without posing any problems.

Yes, of course. Any illness that disrupts body functions and, subsequently, the organs will have an effect on the Proteomis profile. It is important to understand that this is not a diagnostic tool in the classic sense (for example breast cancer, jaundice or a heart attack) but the profile highlights any change in serum proteins that these pathologies produce. The important thing is that it detects disturbances earlier than other conventional medical analyses, which then allows for early therapeutic treatment.

The Proteomis profile is not a direct genetic analysis. It can, however, find comparisons between the profiles of a mother and her children. It can detect a certain predisposition for thyroid conditions.

We already know certain proteins increase in number when the immune system needs to defend itself against certain attacks. Such examples include inflammatory proteins, immunoglobulins etc. These changes are often detectable long before symptoms appear.

The Proteomis profile uses another method to analyze the serum proteins. Thanks to this profiling, organic as well as functional changes are detected. The result is a more finely-tuned, individually-based analysis of the overall biological status of the patient.

The Proteomis profile follows the same protocol as other medical tests. The CEIA Lab laboratory has declared all of its treatments to the Belgian Privacy Commission.

The patient receives a copy of the report at the same time as his/her doctor. The patient should then discuss his/her results with their doctor, so as to fully understand the report and any therapeutic options.

The first profile is sufficient to establish the patient's current health status and treatment options. It is advisable to do a test to evaluate the healing process after three months.